Deprescribing Benzodiazepines: Is Harm Reduction Enough?

References (8)

1. Modesto-Lowe V, Jain L, Rodrigues R. Benzodiazepine use: cross-national perspectives. Fam Pract. 2023;40(1):205–206. PubMed CrossRef
2. Boon M, van Dorp E, Broens S, et al. Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events. Ann Palliat Med. 2020;9(2):542–557. PubMed CrossRef
3. Wang Y, Wilson DL, Fernandes D, et al. Deprescribing strategies for opioids and benzodiazepines with emphasis on concurrent use: a scoping review. J Clin Med. 2023;12(5):1788. PubMed CrossRef
4. Gerlach LB, Strominger J, Kim HM, et al. Discontinuation of chronic benzodiazepine use among adults in the United States. J Gen Intern Med. 2019;34(9):1833–1840. PubMed CrossRef
5. Munipati D, Mathur R, Sarkar S. Rapid detoxification in an adult with benzodiazepine dependence with the aid of an antiepileptic. Prim Care Companion CNS Disord. 2023;25(4):22cr03457. PubMed CrossRef
6. Soni A, Thiyagarajan A, Reeve J. Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis. Addiction. 2023;118(1):7–16. PubMed CrossRef
7. Dou C, Rebane J, Bardal S. Interventions to improve benzodiazepine tapering success in the elderly: a systematic review. Aging Ment Health. 2019;23(4):411–416. PubMed CrossRef
8. Modesto-Lowe V, Kranzler HR. Diagnosis and treatment of alcohol-dependent patients with comorbid psychiatric disorders. Alcohol Res Health. 1999;23(2):144–149. PubMed